These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 31897150)
1. Activity and mechanism of flavokawain A in inhibiting P-glycoprotein expression in paclitaxel resistance of lung cancer. Li J; Zheng L; Yan M; Wu J; Liu Y; Tian X; Jiang W; Zhang L; Wang R Oncol Lett; 2020 Jan; 19(1):379-387. PubMed ID: 31897150 [TBL] [Abstract][Full Text] [Related]
2. Synergistic Combination of Sodium Aescinate-Stabilized, Polymer-Free, Twin-Like Nanoparticles to Reverse Paclitaxel Resistance. Li J; Zheng L; Wang R; Sun D; Liang S; Wu J; Liu Y; Tian X; Li T; Yang Y; Han L Int J Nanomedicine; 2020; 15():5839-5853. PubMed ID: 32848393 [TBL] [Abstract][Full Text] [Related]
3. FKA-A NPs enhances PTX-A NPs efficacy to suppress ovarian cancer via regulating Skp2/YAP pathway. Li J; Wang R; Liu Y; Wu Y; Han L; Zheng L; Bao Z Fundam Clin Pharmacol; 2023 Feb; 37(1):125-136. PubMed ID: 36028983 [TBL] [Abstract][Full Text] [Related]
4. Flavokawain A inhibits Cytochrome P450 in in vitro metabolic and inhibitory investigations. Niu L; Ding L; Lu C; Zuo F; Yao K; Xu S; Li W; Yang D; Xu X J Ethnopharmacol; 2016 Sep; 191():350-359. PubMed ID: 27318274 [TBL] [Abstract][Full Text] [Related]
5. Dietary feeding of Flavokawain A, a Kava chalcone, exhibits a satisfactory safety profile and its association with enhancement of phase II enzymes in mice. Li X; Xu X; Ji T; Liu Z; Gu M; Hoang BH; Zi X Toxicol Rep; 2014; 1():2-11. PubMed ID: 25379458 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-22 (IL-22) Regulates Apoptosis of Paclitaxel-Resistant Non-Small Cell Lung Cancer Cells Through C-Jun N-Terminal Kinase Signaling Pathway. Li C; Zhao X; Yang Y; Liu S; Liu Y; Li X Med Sci Monit; 2018 May; 24():2750-2757. PubMed ID: 29723165 [TBL] [Abstract][Full Text] [Related]
7. Flavokawain A ameliorates pulmonary fibrosis by inhibiting the TGF-β signaling pathway and CXCL12/CXCR4 axis. Xiao T; Gao D; Gu X; Zhang Y; Zhu Y; Zhang Z; He Y; Wei L; Li H; Zhou H; Yang C Eur J Pharmacol; 2023 Nov; 958():175981. PubMed ID: 37579968 [TBL] [Abstract][Full Text] [Related]
8. Kava chalcone, flavokawain A, inhibits urothelial tumorigenesis in the UPII-SV40T transgenic mouse model. Liu Z; Xu X; Li X; Liu S; Simoneau AR; He F; Wu XR; Zi X Cancer Prev Res (Phila); 2013 Dec; 6(12):1365-75. PubMed ID: 24121102 [TBL] [Abstract][Full Text] [Related]
9. Apatinib Reverses Paclitaxel-resistant Lung Cancer Cells (A549) Through Blocking the Function of ABCB1 Transporter. Zhang Q; Song Y; Cheng X; Xu Z; Matthew OA; Wang J; Sun Z; Zhang X Anticancer Res; 2019 Oct; 39(10):5461-5471. PubMed ID: 31570440 [TBL] [Abstract][Full Text] [Related]
10. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction. Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453 [TBL] [Abstract][Full Text] [Related]
11. Flavokawain A alleviates the progression of mouse osteoarthritis: An Jing S; Wan J; Wang T; He Z; Ding Q; Sheng G; Wang S; Zhao H; Zhu Z; Wu H; Li W Front Bioeng Biotechnol; 2022; 10():1071776. PubMed ID: 36545678 [TBL] [Abstract][Full Text] [Related]
12. Combination of shikonin with paclitaxel overcomes multidrug resistance in human ovarian carcinoma cells in a P-gp-independent manner through enhanced ROS generation. Wang Z; Yin J; Li M; Shen J; Xiao Z; Zhao Y; Huang C; Zhang H; Zhang Z; Cho CH; Wu X Chin Med; 2019; 14():7. PubMed ID: 30911326 [TBL] [Abstract][Full Text] [Related]
13. Nobiletin potentiates paclitaxel anticancer efficacy in A549/T xenograft model: Pharmacokinetic and pharmacological study. Feng SL; Tian Y; Huo S; Qu B; Liu RM; Xu P; Li YZ; Xie Y Phytomedicine; 2020 Feb; 67():153141. PubMed ID: 31884406 [TBL] [Abstract][Full Text] [Related]
14. Flavokawain A inhibits prostate cancer cells by inducing cell cycle arrest and cell apoptosis and regulating the glutamine metabolism pathway. Wang K; Zhang W; Wang Z; Gao M; Wang X; Han W; Zhang N; Xu X J Pharm Biomed Anal; 2020 Jul; 186():113288. PubMed ID: 32361091 [TBL] [Abstract][Full Text] [Related]
15. Chemoprevention of Urothelial Cell Carcinoma Tumorigenesis by Dietary Flavokawain A in UPII-Mutant Ha-ras Transgenic Mice. Liu Z; Song L; Xie J; Simoneau AR; Uchio E; Zi X Pharmaceutics; 2022 Feb; 14(3):. PubMed ID: 35335874 [TBL] [Abstract][Full Text] [Related]
16. Flavokawain A Reduces Tumor-Initiating Properties and Stemness of Prostate Cancer. Song L; Mino M; Yamak J; Nguyen V; Lopez D; Pham V; Fazelpour A; Le V; Fu D; Tippin M; Uchio E; Zi X Front Oncol; 2022; 12():943846. PubMed ID: 35912174 [TBL] [Abstract][Full Text] [Related]
17. Flavokawain A induces deNEDDylation and Skp2 degradation leading to inhibition of tumorigenesis and cancer progression in the TRAMP transgenic mouse model. Li X; Yokoyama NN; Zhang S; Ding L; Liu HM; Lilly MB; Mercola D; Zi X Oncotarget; 2015 Dec; 6(39):41809-24. PubMed ID: 26497688 [TBL] [Abstract][Full Text] [Related]
18. Guajadial reverses multidrug resistance by inhibiting ABC transporter expression and suppressing the PI3K/Akt pathway in drug-resistant breast cancer cells. Li Y; Zhai Z; Li H; Wang X; Huang Y; Su X Chem Biol Interact; 2019 May; 305():98-104. PubMed ID: 30929998 [TBL] [Abstract][Full Text] [Related]
19. Paclitaxel resistance in MCF-7/PTX cells is reversed by paeonol through suppression of the SET/phosphatidylinositol 3-kinase/Akt pathway. Zhang W; Cai J; Chen S; Zheng X; Hu S; Dong W; Lu J; Xing J; Dong Y Mol Med Rep; 2015 Jul; 12(1):1506-14. PubMed ID: 25760096 [TBL] [Abstract][Full Text] [Related]
20. Overcoming drug-resistant lung cancer by paclitaxel loaded tetrahedral DNA nanostructures. Xie X; Shao X; Ma W; Zhao D; Shi S; Li Q; Lin Y Nanoscale; 2018 Mar; 10(12):5457-5465. PubMed ID: 29484330 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]